Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 4, 2008, Pages 820-825

  Sun, Xiumei ^a   Zhang, Li ^a   Hill, Peter C ^a   Lowery, Robert ^a   Lee, Anne T ^a   Molyneaux, Robert E ^a   Corso, Paul J ^a   Boyce, Steven W ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Coronary artery bypass grafting; Off pump; On pump; Postoperative vasoplegic syndrome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ELECTIVE SURGERY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; ON PUMP CORONARY SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; UNIVARIATE ANALYSIS; VASOPLEGIC SYNDROME;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SURGICAL; STROKE VOLUME; SYNDROME; VASCULAR RESISTANCE;

EID: 52949091191     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.07.012     Document Type: Article

References (19)

1. Argenziano M., Chen J.M., Choudhri A.F., Cullinane S., Garfein E., Weinberg A.D., Smith C.R., Rose E.A., Landry D.W., and Oz M.C. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 (1998) 973-980
2. Levin R.L., Degrange M.A., Bruno G.F., Del Mazo C.D., Taborda D.J., Griotti J.J., and Boullon F.J. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77 (2004) 496-499
3. Carrel T., Englberger L., Mohacsi P., Neidhart P., and Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. Card Surg 15 (2000) 347-353
4. Ozal E., Kuralay E., Yildirim V., Kilic S., Bolcal C., Kucukarslan N., Gunay C., Demirkilic U., and Tatar H. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 79 (2005) 1615-1619
5. Bernstein A.D., Eng S.D., and Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg 69 (2000) 823-828
6. Mekontso-Dessap A., Houel R., Soustelle C., Kirsch M., Thebert D., and Loisance D.Y. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71 (2001) 1428-1432
7. Leyh R.G., Kofidis T., Struber M., Fischer S., Knobloch K., Wachsmann B., Hagl C., Simon A.R., and Haverich A. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 125 (2003) 1426-1431
8. Boyle E.M., Pohlman T.H., Johson M.C., and Verrier E.D. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 63 (1997) 277-284
9. Ascione R., Lloyd C.T., Underwood M.J., Lotto A.A., Pitsis A.A., and Angelini G.D. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
10. Fromes Y., Gaillard D., Ponzio O., Chauffert M., Gerhardt M.F., Deleuze P., and Bical O.M. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22 (2002) 527-533
11. Shanmugam G. Vasoplegic syndrome-the role of Methylene blue. Eur J Cardiothorac Surg 28 (2005) 705-710
12. Tuman K.J., McCarthy R.J., O'Connor C.J., Holm W.E., and Lvankovich A.D. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 80 (1995) 473-479
13. Weis F., Kilger E., Beiras-Fernandez A., Nassau K., Reuter D., Goetz A., Lamm P., Reindl L., and Briegel J. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 61 (2006) 938-942
14. Kilger E., Weis F., Briegel J., Frey L., Goetz A.E., Reuter D., Nagy A., Schuetz A., Lamm P., Knoll A., and Peter K. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31 (2003) 1068-1074
15. Wang S.Y., Stamler A., Li J., Johnson R.G., and Sellke F.W. Decreased myogenic reactivity in skeletal muscle arterioles after hypothermic cardiopulmonary bypass. J Surg Res 69 (1997) 40-44
16. Raja SG, Fida N. Best evidence topic-cardiac general: should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation? Interact Cardiovasc Thorac Surg 2008;7:470-5.
17. Rastan A.J., Eckenstein J.I., Hentschel B., Funkat A.K., Gummert J.F., Doll N., Walther T., Falk V., and Mohr F.W. Emergency coronary artery bypass graft surgery for acute coronary syndrome. Beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation 114 (2006) I477-I485
18. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., and Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289 (2003) 1799-1804
19. Booth J.V., Ward E.E., Colgan K.C., Funk B.L., El-Moalem H., Smith M.P., Milano C., Smith P.K., Newman M.F., Schwinn D.A., and Duke heart Center Perioperative Desensitization Group. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery?. Anesth Analg 98 (2004) 1224-1231